PVLA Earnings Palvella Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–22 of 22
| Q2 2026 | 2026-06-30 | -2.74 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.20 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -3.71 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -2.63 | 2025-11-12 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.60 | 2026-08-04 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.74 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -7.83 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -7.95 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -4.01 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.54 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | 2.17 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -18.33 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -9.08 | 2024-08-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.21 | 2023-08-10 | 10-Q |
| Q1 2022 | 2022-03-31 | -0.07 | 2022-05-11 | 10-Q |
| FY 2021 | 2021-12-31 | -0.71 | 2022-03-02 | 10-K |
| Q3 2021 | 2021-09-30 | -0.58 | 2021-11-02 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.33 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.07 | 2022-05-11 | 10-Q |
| FY 2021 | 2020-12-31 | -0.68 | 2022-03-02 | 10-K |
| Q3 2021 | 2020-09-30 | -0.42 | 2021-11-02 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.16 | 2021-08-05 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.